Actinogen Medical (ASX: ACW)

ACW · ASX · Australia

Public Market Listing

ACWASX

ASX primary exchange listing

Live quotes, historical charts, and market capitalization for Actinogen Medical (ASX: ACW) are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
Emestedastat(Xanamem)
Phase 2/3
11-beta-HSD1Small molecule
Alzheimer's DiseaseMajor Depressive Disorder

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Quarterly & interim (3)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2026-H1———$4.3Mreport ↗
View 2 more
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-H1—$3.0M$14M$5.4Mreport ↗
2024-H1———$7.5Mreport ↗

Annual history (2 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY——$4.0M$9.5Mreport ↗

Actinogen Medical (ASX: ACW) reported cash and equivalents of $4M and a quarterly net burn of $9.53M for fiscal year 2025.

Figures only: this period's report disclosed no narrative text

View 1 more year
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY———$6.2Mreport ↗